Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 40Carcinoma, Non-Small-Cell Lung 32Colorectal Neoplasms 27Ovarian Neoplasms 23Neoplasms 23Lung Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Pancreatic Neoplasms 17Leukemia, Myeloid, Acute 16Head and Neck Neoplasms 16Lymphoma, Non-Hodgkin 15Neoplasm Metastasis 14Fallopian Tube Neoplasms 14Glioblastoma 13Esophageal Neoplasms 12Rectal Neoplasms 11Lymphoma 11Squamous Cell Carcinoma of Head and Neck 10Central Nervous System Neoplasms 10Carcinoma, Ovarian Epithelial 10Recurrence 9Melanoma 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia 9Stomach Neoplasms 8Prostatic Neoplasms 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Liver Neoplasms 7

Interventions

Ropivacaine 6Anesthesia, General 6Analgesics, Opioid 6Morphine 5Acetaminophen 5Saline Solution 4Lidocaine 4Ketamine 4Fentanyl 4Sodium Chloride 3Dexmedetomidine 3Bupivacaine 3Anesthetics, Local 3Anesthesia, Local 3Acupuncture Therapy 3trimebutine 3-thiocarbamoylbenzenesulfonate 2parecoxib 2Transcutaneous Electric Nerve Stimulation 2Tramadol 2Therapeutics 2Tea 2Surveys and Questionnaires 2Propofol 2Oxycodone 2Magnesium Sulfate 2Levobupivacaine 2Control Groups 2ramosetron 1acetaminophen, codeine drug combination 1Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Agnosia × Drug Therapy × Clear all
NCT07152938 2025-09-15

AVR-CHEMO

Arab American University (Palestine)

Phase NA Completed
150 enrolled
BreastGastrointestinalLymphoidPlasma cell

Agnosia, Anxiety Disorders, Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡